GLAND PHARMA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,764 INR | -0.05% |
|
-1.61% | -8.36% |
| Apr. 08 | Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals | CI |
| Apr. 08 | Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection | MT |
Presentation Operator MessageOperator (Operator)Good day and welcome to Gland Pharma conferenc...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, NCE-1s (New Chemical Entities), First-to-File products, and 505(b)(2) filings. The Company functions primarily on a business-to-business (B2B) model and has a record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The Company offers a range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. It is also in the process of including new delivery systems such as pens and cartridges into its product portfolio. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynaecological, Hormones, and others.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
1,764
INR
Average target price
1,856
INR
Spread / Average Target
+5.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.36% | 3.48B | |
| +24.61% | 672B | |
| +24.08% | 550B | |
| -5.55% | 351B | |
| +15.40% | 317B | |
| +7.42% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.76% | 144B | |
| -6.64% | 141B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Transcript : Cenexi - Laboratoires Thissen SA, Gland Pharma Limited - M&A Call
